Glomerular Filtration Markers: Current and Emerging Insights.

IF 7.1 1区 医学 Q1 UROLOGY & NEPHROLOGY
Andrew S Levey,Sharanya Ramesh,Lesley A Inker
{"title":"Glomerular Filtration Markers: Current and Emerging Insights.","authors":"Andrew S Levey,Sharanya Ramesh,Lesley A Inker","doi":"10.2215/cjn.0000001090","DOIUrl":null,"url":null,"abstract":"Glomerular filtration markers are exogenous or endogenous solutes that are eliminated from the circulation primarily by glomerular filtration. Their rate of elimination is directly related to the glomerular filtration rate (GFR), and their plasma concentration is inversely related to the GFR. GFR cannot be measured directly in humans, but it can be assessed by using filtration markers - either as measured GFR (mGFR) from clearance measurements using exogenous filtration markers (such as iothalamate and iohexol), or as estimated GFR (eGFR) from estimating equations using plasma concentrations of endogenous filtration markers (metabolites, such as creatinine, and low molecular weight proteins, such as cystatin C). Thus, both mGFR and eGFR may differ from true GFR, and understanding the physiologic processes affecting filtration markers is required for clinical evaluation of GFR. Processes other than GFR that affect the plasma concentration of filtration markers are collectively defined as non-GFR determinants. By design, exogenous filtration markers are minimally affected by non-GFR determinants, but both urinary and plasma clearance measurements are associated with error in mGFR. In contrast, by definition, all endogenous filtration markers are affected by non-GFR determinants, but not by error in clearance measurements. The major limitations of mGFR procedures are complexity and inconvenience of clearance measurements, which constrain their utility in clinical practice. The major limitation of eGFR is error due to variation in the non-GFR determinants of the filtration markers, which can be minimized by use of a panel of markers (panel eGFR). There is ongoing interest in the discovery of new exogenous filtration markers that would enable widespread implementation of mGFR procedures and novel metabolite and low molecular weight endogenous filtration markers that would enable a panel eGFR. In this Review, we discuss current and emerging insights into existing and novel filtration markers.","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"242 1","pages":""},"PeriodicalIF":7.1000,"publicationDate":"2026-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Journal of the American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2215/cjn.0000001090","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Glomerular filtration markers are exogenous or endogenous solutes that are eliminated from the circulation primarily by glomerular filtration. Their rate of elimination is directly related to the glomerular filtration rate (GFR), and their plasma concentration is inversely related to the GFR. GFR cannot be measured directly in humans, but it can be assessed by using filtration markers - either as measured GFR (mGFR) from clearance measurements using exogenous filtration markers (such as iothalamate and iohexol), or as estimated GFR (eGFR) from estimating equations using plasma concentrations of endogenous filtration markers (metabolites, such as creatinine, and low molecular weight proteins, such as cystatin C). Thus, both mGFR and eGFR may differ from true GFR, and understanding the physiologic processes affecting filtration markers is required for clinical evaluation of GFR. Processes other than GFR that affect the plasma concentration of filtration markers are collectively defined as non-GFR determinants. By design, exogenous filtration markers are minimally affected by non-GFR determinants, but both urinary and plasma clearance measurements are associated with error in mGFR. In contrast, by definition, all endogenous filtration markers are affected by non-GFR determinants, but not by error in clearance measurements. The major limitations of mGFR procedures are complexity and inconvenience of clearance measurements, which constrain their utility in clinical practice. The major limitation of eGFR is error due to variation in the non-GFR determinants of the filtration markers, which can be minimized by use of a panel of markers (panel eGFR). There is ongoing interest in the discovery of new exogenous filtration markers that would enable widespread implementation of mGFR procedures and novel metabolite and low molecular weight endogenous filtration markers that would enable a panel eGFR. In this Review, we discuss current and emerging insights into existing and novel filtration markers.
肾小球滤过标志物:当前和新兴的见解。
肾小球滤过标志物是主要通过肾小球滤过从循环中清除的外源性或内源性溶质。它们的消除率与肾小球滤过率(GFR)直接相关,血浆浓度与GFR呈负相关。GFR不能在人体中直接测量,但可以通过使用过滤标记进行评估——要么是使用外源性过滤标记(如碘甲酸酯和碘己醇)通过清除率测量测量的GFR (mGFR),要么是使用内源性过滤标记(代谢物,如肌酐和低分子量蛋白质,如胱抑素C)的血浆浓度估算方程估算的GFR (eGFR)。因此,mGFR和eGFR可能不同于真实的GFR,了解影响过滤标志物的生理过程是临床评估GFR的必要条件。除GFR外影响血浆滤过标志物浓度的过程统称为非GFR决定因素。通过设计,外源性过滤标记物受非gfr决定因素的影响最小,但尿液和血浆清除率测量与mGFR误差相关。相反,根据定义,所有内源性过滤标记都受非gfr决定因素的影响,但不受清除率测量误差的影响。mGFR手术的主要局限性是清除率测量的复杂性和不方便,这限制了其在临床实践中的应用。eGFR的主要限制是由于过滤标记的非gfr决定因素的变化而产生的误差,这可以通过使用标记面板(面板eGFR)来最小化。人们一直对发现新的外源性过滤标记物感兴趣,这些标记物将使mGFR程序的广泛实施,以及新的代谢物和低分子量内源性过滤标记物将使面板eGFR成为可能。在这篇综述中,我们讨论了当前和新兴的见解,现有的和新的过滤标记。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
12.20
自引率
3.10%
发文量
514
审稿时长
3-6 weeks
期刊介绍: The Clinical Journal of the American Society of Nephrology strives to establish itself as the foremost authority in communicating and influencing advances in clinical nephrology by (1) swiftly and effectively disseminating pivotal developments in clinical and translational research in nephrology, encompassing innovations in research methods and care delivery; (2) providing context for these advances in relation to future research directions and patient care; and (3) becoming a key voice on issues with potential implications for the clinical practice of nephrology, particularly within the United States. Original manuscript topics cover a range of areas, including Acid/Base and Electrolyte Disorders, Acute Kidney Injury and ICU Nephrology, Chronic Kidney Disease, Clinical Nephrology, Cystic Kidney Disease, Diabetes and the Kidney, Genetics, Geriatric and Palliative Nephrology, Glomerular and Tubulointerstitial Diseases, Hypertension, Maintenance Dialysis, Mineral Metabolism, Nephrolithiasis, and Transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书